{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:54:08Z","timestamp":1767167648555,"version":"build-2238731810"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["2018WS241"],"award-info":[{"award-number":["2018WS241"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,8,27]]},"abstract":"\n Objective. To compare the clinical efficacy and adverse drug reactions of four different schemes in the treatment of pleural tuberculoma. Methods. A total of 120 patients with pleural tuberculoma admitted to the Tuberculosis Department of our hospital from January 2018 to January 2021 were selected as the research subjects. According to different treatment methods, the patients were divided into four groups, with 30 cases in each group. They were as follows: group A received classical HRZE regimen, group B received HRZE+pleural injection, group C received HZE+rifabutin, and group D received HZE+rifabutin+pleural injection. All patients were treated intensively for 3 months and then consolidated treatment for 6 months according to the patient\u2019s condition. The absorption of lesions in the four groups at different time was compared, and the occurrences of adverse drug reactions and treatment outcomes during treatment were recorded. Results. After 3 months of treatment, compared with groups A, B, and C, the number of significantly absorbed cases and effective cases in group D increased, while the number of invalid cases decreased. However, there was no statistical significance in the absorption of lesions between the four groups (\n \n \n \n \n \u03c7<\/a:mi>\n <\/a:mrow>\n \n 2<\/a:mn>\n <\/a:mrow>\n <\/a:msup>\n =<\/a:mo>\n 8.272<\/a:mn>\n <\/a:math>\n <\/jats:inline-formula>\n ,\n \n \n P<\/c:mi>\n =<\/c:mo>\n 0.507<\/c:mn>\n <\/c:math>\n <\/jats:inline-formula>\n ). In addition, pairwise comparison showed no significant difference in the absorption of lesions (\n \n \n P<\/e:mi>\n ><\/e:mo>\n 0.05<\/e:mn>\n <\/e:math>\n <\/jats:inline-formula>\n ). After 9 months of treatment, there was no significant difference in the absorption of lesions among the four groups (\n \n \n \n \n \u03c7<\/g:mi>\n <\/g:mrow>\n \n 2<\/g:mn>\n <\/g:mrow>\n <\/g:msup>\n =<\/g:mo>\n 8.795<\/g:mn>\n <\/g:math>\n <\/jats:inline-formula>\n ,\n \n \n P<\/i:mi>\n =<\/i:mo>\n 0.185<\/i:mn>\n <\/i:math>\n <\/jats:inline-formula>\n ), but the absorption of lesions in group D was significantly better than that in group A (\n \n \n P<\/k:mi>\n <<\/k:mo>\n 0.05<\/k:mn>\n <\/k:math>\n <\/jats:inline-formula>\n ). During treatment, the incidence of adverse reactions in the four groups was significantly different (\n \n \n \n \n \u03c7<\/m:mi>\n <\/m:mrow>\n \n 2<\/m:mn>\n <\/m:mrow>\n <\/m:msup>\n =<\/m:mo>\n 8.779<\/m:mn>\n <\/m:math>\n <\/jats:inline-formula>\n ,\n \n \n P<\/o:mi>\n =<\/o:mo>\n 0.032<\/o:mn>\n <\/o:math>\n <\/jats:inline-formula>\n ). Pairwise comparison showed that the incidence of adverse reactions in groups C and D was significantly lower than that in group A (\n \n \n P<\/q:mi>\n <<\/q:mo>\n 0.05<\/q:mn>\n <\/q:math>\n <\/jats:inline-formula>\n ). The total treatment course of group A was 9-16 months, and 10 cases (33.33%) still had residual lesions or pleural thickening at the end of treatment. The total course of treatment in group B was 9-12 months, and 7 cases (23.33%) still had residual lesions or pleural thickening at the end of the course of treatment. The total treatment course of group C was 9-16 months, and 8 cases (26.67%) still had residual lesions or pleural thickening at the end of treatment. The total course of treatment in group D was 9-12months, and there were still 2 cases of residual lesions (6.67%) at the end of the course. Conclusions. HZE+rifabutin+pleural injection against tuberculosis therapy has a significant clinical efficacy in the treatment of pleural tuberculoma, which can more effectively improve the clinical symptoms of patients, improve the efficacy, and reduce complications, with a good prognosis, worthy of clinical promotion.\n <\/jats:p>","DOI":"10.1155\/2022\/5666067","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T15:35:20Z","timestamp":1661614520000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Study of Different Treatment Methods for Tuberculous Pleuritis Complicated with Pleural Tuberculoma"],"prefix":"10.1155","volume":"2022","author":[{"given":"Xiaoling","family":"Zhang","sequence":"first","affiliation":[{"name":"Four Tuberculosis Areas, Shandong Public Health Clinical Center, Jinan, Shandong 250001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-5619","authenticated-orcid":true,"given":"Jingyu","family":"Chi","sequence":"additional","affiliation":[{"name":"Four Tuberculosis Areas, Shandong Public Health Clinical Center, Jinan, Shandong 250001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"issue":"1","key":"1","article-title":"Advances in the diagnosis and treatment of tuberculous pleurisy","volume":"32","author":"X. Y. Chen","year":"2016","journal-title":"Tuberculosis and Thoracic Tumors"},{"issue":"6","key":"2","first-page":"104","article-title":"Clinical characteristics and diagnosis-treatment experience of 20 cases of pleural tuberculoma","volume":"32","author":"S. P. Cao","year":"2019","journal-title":"Clinical Misdiagnosis & Mistherapy"},{"issue":"8","key":"3","first-page":"1252","article-title":"Clinical application of CT-guided percutaneous puncture in biopsy and treatment of patients with pleural tuberculoma","volume":"25","author":"G. H. Jie","year":"2020","journal-title":"Journal of Clinical Pulmonology"},{"issue":"2","key":"4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4269\/ajtmh.21-0740","article-title":"Uncommon presentation of tuberculosis as an incidentally discovered solitary pleural tuberculoma","volume":"106","author":"T. Kinjo","year":"2022","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"5","article-title":"Clinical Characteristics and Diagnosis-treatment Experience of 20 Cases of Pleural Tuberculoma [J]","author":"S. P. Cao","year":"2019","journal-title":"Clinical Misdiagnosis & Mistherapy"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjab408"},{"issue":"8","key":"7","first-page":"45","article-title":"Imaging diagnosis and surgical treatment of pleural tuberculosis","volume":"31","author":"H. Wang","year":"2008","journal-title":"Middle Journal of Advanced Study of Chinese Physicians"},{"issue":"4","key":"8","first-page":"306","article-title":"Study on the risk factors of tuberculous pleurisy complicated with pleural tuberculoma","volume":"40","author":"L. Fan","year":"2017","journal-title":"Chinese Journal of Tuberculosis and Respiratory Medicine"},{"issue":"14","key":"9","first-page":"2348","article-title":"Clinical analysis of 32 cases of pleural tuberculoma during the treatment of tuberculous pleurisy","volume":"49","author":"W. L. Kong","year":"2020","journal-title":"Chongqing Medicine"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S277203"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa460"},{"issue":"11","key":"12","first-page":"2335","article-title":"Research progress on clinical application of rifamycin in treatment of tuberculosis","volume":"43","author":"L. M. Lin","year":"2020","journal-title":"Drug Evaluation Research"},{"issue":"20","key":"13","first-page":"1521","article-title":"Research progress of pathogenesis and treatment of pleural tuberculoma","volume":"41","author":"W. W. Gao","year":"2021","journal-title":"International Journal of Respiration"},{"key":"14","volume-title":"Clinical Diagnosis and Treatment Guidelines: Tuberculosis Volume","author":"Chinese Medical Association","year":"2005"},{"issue":"4","key":"15","first-page":"73","article-title":"Observation of clinical features of AIDS complicated with tuberculosis","volume":"14","author":"L. M. Wang","year":"2019","journal-title":"China Practical Medicine"},{"issue":"20, article 5","key":"16","article-title":"Research progress on the pathogenesis and treatment of pleural tuberculoma","volume":"41","author":"W. W. Gao","year":"2021","journal-title":"International Journal of Respiratory Medicine"},{"key":"17","first-page":"2868","article-title":"Effect of intrapleural injection of glucocorticoid combined with standard quadruple anti tuberculous therapy on clinical symptoms and pulmonary function of patients with tuberculous pleurisy","volume":"15","author":"X. N. Ma","year":"2021","journal-title":"Progress in Modern Biomedicine"},{"issue":"3","key":"18","first-page":"3","article-title":"Analysis of the influencing factors of pleural tuberculoma in patients with tuberculous pleurisy","volume":"57","author":"Y. Li","year":"2022","journal-title":"Journal of Anhui Medical University"},{"issue":"7","key":"19","first-page":"4","article-title":"Analysis of CT features and differential diagnosis of pleural tuberculoma","volume":"28","author":"M. Xue","year":"2018","journal-title":"Journal of Medical Imaging"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30575-4"},{"issue":"2","key":"21","first-page":"160","article-title":"Analysis on the incidence of adverse reaction and risk factors caused by anti-tuberculosis drugs","volume":"21","author":"J. I. A. N. G. Bo-feng","year":"2017","journal-title":"Chinese Journal of Disease Control & Prevention"},{"issue":"32","key":"22","first-page":"111","article-title":"Research progress on adverse reactions of anti-tuberculosis drugs","volume":"59","author":"Y. J. Ma","year":"2019","journal-title":"Shandong Medicine"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.13836"},{"issue":"12","key":"24","first-page":"2058","article-title":"Risk factors for tuberculosis chemotherapeutic drug pyrazinamide-induced hyperuricemia","volume":"19","author":"P. U. Qiang-hong","year":"2021","journal-title":"Chinese Journal of General Practice"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i2.663"},{"key":"26","article-title":"Pulmonary delivery of rifabutin utilizing modified chitosan nanocapsules","author":"R. Haddad","year":"2021"},{"issue":"3, article 255","key":"27","article-title":"Clinical characteristics and treatment outcomes of 18 patients with non-tuberculosis mycobacteria concerning eyes, ears, nose and throat","volume":"42","author":"Y. L. Jian","year":"2020","journal-title":"Chinese Journal of Antituberculosis"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00345"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112338-20191121-00823"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.113076"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1809"},{"issue":"1","key":"32","first-page":"77","article-title":"Evaluation of the effect of different doses of isoniazid in the treatment of tuberculous meningitis","volume":"38","author":"J. He","year":"2021","journal-title":"Chinese Journal of Metallurgical Industry and Medicine"}],"updated-by":[{"DOI":"10.1155\/2023\/9847416","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"record-id":"47277"},{"DOI":"10.1155\/2023\/9847416","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000}}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5666067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5666067.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5666067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T15:35:40Z","timestamp":1661614540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/5666067\/"}},"subtitle":[],"editor":[{"given":"Pan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":32,"alternative-id":["5666067","5666067"],"URL":"https:\/\/doi.org\/10.1155\/2022\/5666067","relation":{},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,27]]}}}